title: Oral administration of vinorelbine can overcome intractable endovenous-vinorelbine-associated acute tumor pain.
authors.affiliation: Department of Medical Oncology, European Institute of Oncology, Milan, Italy. tommaso.de-pas@ieo.it
authors.forename: T
authors.initials: T
authors.lastname: De Pas
authors.forename: A
authors.initials: A
authors.lastname: Sbanotto
authors.forename: C
authors.initials: C
authors.lastname: Catania
authors.forename: M G
authors.initials: MG
authors.lastname: Banfi
authors.forename: G
authors.initials: G
authors.lastname: Curigliano
authors.forename: F
authors.initials: F
authors.lastname: Nolè
authors.forename: N
authors.initials: N
authors.lastname: Fazio
authors.forename: V
authors.initials: V
authors.lastname: Formica
authors.forename: G
authors.initials: G
authors.lastname: Veronesi
authors.forename: F
authors.initials: F
authors.lastname: de Braud
mesh_terms: D000208:Acute Disease; D000230:Adenocarcinoma / Q000150:complications / Q000175:diagnosis / Q000628:therapy; D000284:Administration, Oral; D000368:Aged; D002289:Carcinoma, Non-Small-Cell Lung / Q000150:complications / Q000175:diagnosis / Q000628:therapy; D004305:Dose-Response Relationship, Drug; D004334:Drug Administration Schedule; D005500:Follow-Up Studies; D006801:Humans; D007262:Infusions, Intravenous; D008175:Lung Neoplasms / Q000150:complications / Q000175:diagnosis / Q000628:therapy; D008297:Male; D008875:Middle Aged; D010147:Pain Measurement; D010148:Intractable Pain / Q000188:drug therapy* / Q000209:etiology; D012720:Severity of Illness Index; D013274:Stomach Neoplasms / Q000150:complications / Q000175:diagnosis / Q000628:therapy; D014747:Vinblastine / Q000008:administration & dosage* / Q000009:adverse effects / Q000031:analogs & derivatives*; D000077235:Vinorelbine
chemical_list: D014747:Vinblastine; D000077235:Vinorelbine